Zobrazeno 1 - 6
of 6
pro vyhledávání: '"JianXun Cai"'
Autor:
Hairun Gan, Luting Li, Xinyan Hu, Jianxun Cai, Xiaojun Hu, Haopei Zhang, Ni Zhao, Xiwei Xu, Hui Guo, Pengfei Pang
Publikováno v:
Cancer Biology & Therapy, Vol 23, Iss 1, Pp 1-14 (2022)
Sorafenib (SFN) is a multi-kinase inhibitor drug for the treatment of advanced hepatocellular carcinoma (HCC), but its limited efficacy is a major obstacle to the clinical outcomes of patients with HCC. We aimed to explore a novel molecular mechanism
Externí odkaz:
https://doaj.org/article/b6c0da535fbb4b6281d0e7e93cac9adf
Autor:
Hairun Gan, Jiumeng Min, Haoyu Long, Bing Li, Xinyan Hu, Zhongyi Zhu, Luting Li, Tiancheng Wang, Xiangyan He, Jianxun Cai, Yongyu Zhang, Jianan He, Luan Chen, Dashuai Wang, Jintao Su, Ni Zhao, Weile Huang, Jingjing Zhang, Ziqi Su, Hui Guo, Xiaojun Hu, Junjie Mao, Jinmin Ma, Pengfei Pang
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
The high morbidity of patients with coronavirus disease 2019 (COVID-19) brings on a panic around the world. COVID-19 is associated with sex bias, immune system, and preexisting chronic diseases. We analyzed the gene expression in patients with COVID-
Externí odkaz:
https://doaj.org/article/57a6ba47406b4d51a7230f667d247f21
Autor:
Tianze Liu, Hairun Gan, Simeng He, Jia Deng, Xinyan Hu, Luting Li, Li Cai, Jianzhong He, Haoyu Long, Jianxun Cai, Hanjie Li, Qianqian Zhang, Lijie Wang, Fangbin Chen, Yuming Chen, Haopei Zhang, Jian Li, Lukun Yang, Ye Liu, Jian-Hua Yang, Dong-Ming Kuang, Pengfei Pang, Huanhuan He, Hong Shan
Publikováno v:
Cancer Research. 82:3074-3087
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies. Elucidating the underlying mechanisms of this disease could provide new therapeutic strategies for treating HCC. Here, we identified a novel role of DEAD-box helicase 24 (DDX2
Autor:
Hong Shan, Huanhuan He, Pengfei Pang, Dong-Ming Kuang, Jian-Hua Yang, Ye Liu, Lukun Yang, Jian Li, Haopei Zhang, Yuming Chen, Fangbin Chen, Lijie Wang, Qianqian Zhang, Hanjie Li, Jianxun Cai, Haoyu Long, Jianzhong He, Li Cai, Luting Li, Xinyan Hu, Jia Deng, Simeng He, Hairun Gan, Tianze Liu
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies. Elucidating the underlying mechanisms of this disease could provide new therapeutic strategies for treating HCC. Here, we identified a novel role of DEAD-box helicase 24 (DDX2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0efbb15ccb74a62791e06c4692481e
https://doi.org/10.1158/0008-5472.c.6513983
https://doi.org/10.1158/0008-5472.c.6513983
Autor:
Hong Shan, Huanhuan He, Pengfei Pang, Dong-Ming Kuang, Jian-Hua Yang, Ye Liu, Lukun Yang, Jian Li, Haopei Zhang, Yuming Chen, Fangbin Chen, Lijie Wang, Qianqian Zhang, Hanjie Li, Jianxun Cai, Haoyu Long, Jianzhong He, Li Cai, Luting Li, Xinyan Hu, Jia Deng, Simeng He, Hairun Gan, Tianze Liu
Supplementary Data from RNA Helicase DDX24 Stabilizes LAMB1 to Promote Hepatocellular Carcinoma Progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::556e744a6a796001254ab399b76c5b88
https://doi.org/10.1158/0008-5472.22431776
https://doi.org/10.1158/0008-5472.22431776
Autor:
TianCheng Wang, MinZhao Lin, JunJie Mao, LiRong Tian, HaiRun Gan, XinYan Hu, LeYe Yan, HaoYu Long, JianXun Cai, XiaoDi Zheng, YuDong Xiao, Dan Li, XinTao Shuai, PengFei Pang
Publikováno v:
ACS applied materialsinterfaces.
Immune checkpoint blockade (ICB) utilizing programmed death ligand-1 (PD-L1) antibody is a promising treatment strategy in solid tumors. However, in fact, more than half of hepatocellular carcinoma (HCC) patients are unresponsive to PD-L1-based ICB t